The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 903-908

  Mendoza Gamboa, Edgar ^a   Siwak, Doris R ^a   Tari, Ana M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Akt; AP 1; Grb2; HER2

Indexed keywords

AKT1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GRB2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; ONCOPROTEIN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RETINOIC ACID; RETINOIC ACID RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BREAST TUMOR; CELL CULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; FEMALE; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; METABOLISM; ONCOGENE; PHYSIOLOGY; SRC HOMOLOGY DOMAIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENES, JUN; GRB2 ADAPTOR PROTEIN; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; RECEPTORS, RETINOIC ACID; SRC HOMOLOGY DOMAINS; TRANSCRIPTION FACTOR AP-1; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 16644375433     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.903     Document Type: Article

References (15)

1. Angel P and Karin M: The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991. (Pubitemid 121007534)
2. Shaulian E and Karin M: AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001. (Pubitemid 32531297)
3. Sistonen L, Holtta E, Lahvaslaiho H, Lehtola L and Alitalo K: Activation of the neu tyrosine kinase induced the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase. J Cell Biol 109: 1911-1919, 1989. (Pubitemid 19282583)
4. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG and Hauser CA: Oncogenic Neu/ErbB-2 increases ets, AP-1 and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem271: 7992-7998, 1996. (Pubitemid 26108618)
5. Smith L, Birrer M, Stampfer M and Brown P: Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells. Cancer Res 57: 3046-3054, 1997. (Pubitemid 27315059)
6. Yang L, Kim H, Munoz-Medellin D, Reddy P and Brown P: Induction of retinoid resistance in breast cancer cells by over-expression of cJun. Cancer Res 57: 4652-4661, 1997. (Pubitemid 27441074)
7. Siwak D, Mendoza-Gamboa E and Tari AM: HER2/neu uses Akt to suppress retinoic acid response element binding activity in MDA-MB-453 breast cancer cells. Int J Oncol 23: 1739-1745, 2003.
8. Lim S-J, Lopez-Berestein G, Hung M-C, Lupu R and Tari A: Grb2 down-regulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells. Oncogene 19: 6271-6276, 2000. (Pubitemid 32641840)
9. Tari A, Lim S-J, Hung M-C, Esteva F and Lopez-Berestein G: HER2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene 21: 5224-5232, 2002. (Pubitemid 34948134)
10. Tari A: Preparation and application of liposome-incorporated antisense oligonucleotides. Methods Enzymol 313: 372-388, 2000.
11. Dunn SE, Torres JV, Oh IS, Cykert DM and Barrett JC: Upregulation of urokinase-type plasminogen activator by insulinlike growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase. Cancer Res 61: 1367-1374, 2001. (Pubitemid 34292558)
12. Tari A, Hung M-C, Li K and Lopez-Berestein G: Growth inhibition of breast cancer cells by Grb2 down-regulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene 18: 1325-1332, 1999. (Pubitemid 29094884)
13. Tari A and Lopez-Berestein G: Serum predominantly leads to activation of MAPK and Akt kinases in EGFR and ErbB2 over-expressing cells, respectively. Int J Cancer 86: 295-297, 2000. (Pubitemid 30180828)
14. Zhang L, Bewick M and Lafrenie RM: EGFR and ErbB2 differentially regulate Raf-1 translocation and activation. Lab Invest 82: 71-78, 2002. (Pubitemid 34072647)
15. Muthuswamy SK, Li D, Lelievre S, Bissell MJ and Brugge JS: ErbB2, but not ErbBl, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 3: 785-792, 2001. (Pubitemid 32842683)